Antistatic v2 is available to try at v2.antistatic.exchange
antistatic.exchange
Register Log in

Anthropic safety capability thresholds

By end of 2026 By end of 2026
7.6%
Adjust month-by-month → →
By end of 2027 By end of 2027
52.0%
Adjust month-by-month → →
By end of 2028 By end of 2028
73.8%
Adjust month-by-month → →
By end of 2029 By end of 2029
84.2%
Adjust month-by-month → →
By end of 2030 By end of 2030
88.8%
Adjust month-by-month → →
Log in to submit a forecast.

2 comments

Log in to comment.

1

Anthropic’s head of life sciences, Eric Kauderer-Abrams, confirmed that the company is conducting physical biology experiments in its own laboratory and with external partners. He described automation of laboratory execution as being at an early stage. Reuters also reports work toward having Claude direct laboratory robots with limited human intervention; Anthropic says human oversight remains essential. Reuters, September 18: Anthropic’s laboratory work and automation plans.

1

Anthropic’s October 27 update reports roughly 35,000 Claude-designed antibodies in a month, with lab-confirmed hits. Its acquired Mithril program targets human trials from late 2028; most work remains preclinical. Update